Industries > Pharma > Global Neurovascular Devices Market Forecast to 2027

Global Neurovascular Devices Market Forecast to 2027

Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices

PUBLISHED: 11 January 2018
PAGES: 152
PRODUCT CODE: PHA0274

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The global neurovascular devices market is expected to grow at a CAGR of 10.3% in the first half of the forecast period. In 2016, the Cerebral Embolization and Aneurysm Coiling Devices segment held the largest share in the global neurovascular devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 152-page report you will receive 85 charts– all unavailable elsewhere.

The 152-page report provides clear detailed insight into the global neurovascular devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Global Neurovascular Devices Market Forecast to 2027

Report Scope

• Global Neurovascular Devices market forecasts to 2027

• This report also breaks down the revenue forecast for the global neurovascular market by submarket
– Cerebral Embolization and Aneurysm Coiling Devices
– Cerebral Angioplasty and Stenting Systems
– Support Devices
– Neurothrombectomy Devices

• This report provides individual revenue forecasts to 2027 for these regional and national markets:
– The US
– EU5: Germany, France, the UK, Italy, Spain
– Japan
– BRIC: Brazil, Russia, India, China
– Rest of the World (RoW)

• Our study gives qualitative analysis of the neurovascular devices market. It discusses the SWOT analysis of the neurovascular devices market.

• Our study discusses the selected leading companies that are the major players in the neurovascular devices industry:
– Stryker Corporation
– Medtronic
– Johnson & Johnson
– Terumo
– Penumbra

Visiongain’s study is intended for anyone requiring commercial analyses for the global b neurovascular devices market. You find data, trends and predictions.

Buy our report today Global Neurovascular Devices Market Forecast to 2027: Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Neurovascular Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Neurovascular Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2022-2032

The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.

13 September 2022

READ